-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
-
Summary
-
Zenas BioPharma, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from Q1 2023 to Q2 2025.
- Zenas BioPharma, Inc. Net Income (Loss) Attributable to Parent for the quarter ending June 30, 2025 was -$52.2M, a 37.5% decline year-over-year.
- Zenas BioPharma, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending June 30, 2025 was -$177M, a 223% decline year-over-year.
- Zenas BioPharma, Inc. annual Net Income (Loss) Attributable to Parent for 2024 was -$157M, a 323% decline from 2023.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)